{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:00:26Z","timestamp":1773212426167,"version":"3.50.1"},"reference-count":22,"publisher":"Tech Science Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2017,1,26]]},"abstract":"<jats:p>Ovarian cancer is one of the leading causes of gynecological cancer-related deaths worldwide. We investigated the role of a newly discovered long noncoding RNA, NR_026689, in cell proliferation, metastasis, and apoptosis in ovarian cancer cells. Our results showed that NR_026689 was\n overexpressed in both clinical ovarian cancer patients and cultured ovarian cancer cells. Knockdown of NR_026689 in HO-8910PM cells significantly decreased the cell proliferative rate and the ability to form colonies. Transwell assays revealed that depletion of NR_026689 suppressed cell migration\n ability by 68% and cell invasive capacity by 71% in HO-8910PM cells. Moreover, specific shRNAs against NR_026689 notably promoted cell apoptosis in HO-8910PM cells by upregulating the expression of proapoptotic proteins, including caspase 3, caspase 9, cytochrome C, and PARP. Our study suggests\n an oncogenic potential of NR_026689 in ovarian cancer and might provide novel clues for the diagnosis and treatment of ovarian cancer in the clinic.<\/jats:p>","DOI":"10.3727\/096504016x14732503870766","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T04:33:46Z","timestamp":1473741226000},"page":"259-265","source":"Crossref","is-referenced-by-count":6,"title":["Knockdown of Long Noncoding RNA NR_026689 Inhibits Proliferation and Invasion and Increases Apoptosis in Ovarian Carcinoma HO-8910PM Cells"],"prefix":"10.32604","volume":"25","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaowen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunli","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuying","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","reference":[{"issue":"2","key":"b1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","year":"2015","journal-title":"CA CancerJ Clin."},{"issue":"6","key":"b2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","year":"2011","journal-title":"Am J Obstet Gynecol."},{"issue":"1","key":"b3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","year":"1996","journal-title":"N Engl J Med."},{"issue":"7","key":"b4","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.1120733109","article-title":"Human ovarian cancer stem\/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance","volume":"109","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"b5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2009.06.031","article-title":"Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer","volume":"115","year":"2009","journal-title":"Gynecol Oncol."},{"issue":"7","key":"b6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1200\/JCO.2006.08.8583","article-title":"Tumor vascular proteins as biomarkers in ovarian cancer","volume":"25","year":"2007","journal-title":"J Clin Oncol."},{"issue":"11","key":"b7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.5732\/cjc.013.10170","article-title":"Noncoding RNAs in cancer and cancer stem cells","volume":"32","year":"2013","journal-title":"Chin J Cancer"},{"issue":"9","key":"b8","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression","volume":"22","year":"2012","journal-title":"Genome Res."},{"issue":"5","key":"b9","first-page":"e155250","article-title":"The long noncoding RNA MALAT-1 is highly expressed in ovarian cancer and induces cell growth and migration","volume":"11","year":"2016","journal-title":"PLoS One"},{"issue":"22","key":"b10","first-page":"32487","article-title":"The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer","volume":"7","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"b11","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.18632\/oncotarget.7475","article-title":"Identification of a long non-coding RNA NR_026689 associated with lung carcinogenesis induced by NNK","volume":"7","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"b12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","year":"1996","journal-title":"N Engl J Med."},{"key":"b13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.biopha.2016.04.034","article-title":"miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2","volume":"81","year":"2016","journal-title":"Biomed Pharmacother."},{"issue":"27","key":"b14","first-page":"42183","article-title":"Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO","volume":"7","year":"2016","journal-title":"Oncotarget"},{"issue":"26","key":"b15","doi-asserted-by":"crossref","first-page":"40266","DOI":"10.18632\/oncotarget.9733","article-title":"JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN\/AKT signaling","volume":"7","year":"2016","journal-title":"Oncotarget"},{"issue":"5203","key":"b16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1126\/science.7878464","article-title":"Apoptosis in the pathogenesis and treatment of disease","volume":"267","year":"1995","journal-title":"Science"},{"issue":"4","key":"b17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1440-1681.1999.03031.x","article-title":"Regulation of caspase activation in apoptosis: Implications in pathogenesis and treatment of disease","volume":"26","year":"1999","journal-title":"Clin Exp Pharmacol Physiol."},{"issue":"8","key":"b18","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.cdd.4401949","article-title":"Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis?","volume":"13","year":"2006","journal-title":"Cell Death Differ."},{"key":"b19","first-page":"Unit2.12","article-title":"Detection of the mitochondrial apoptosis-induced channel (MAC) and its regulation by Bcl-2 family proteins","volume":"Chapter 2","year":"2006","journal-title":"Curr Protoc Toxicol."},{"issue":"2","key":"b20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbadis.2005.07.002","article-title":"Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins","volume":"1762","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"b21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.cdd.4400597","article-title":"Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells","volume":"7","year":"2000","journal-title":"Cell Death Differ."},{"issue":"49","key":"b22","doi-asserted-by":"crossref","first-page":"40985","DOI":"10.1074\/jbc.M502190200","article-title":"The lysosome-associated apoptosis-inducing protein containing the pleckstrin homology (PH) and FYVE domains (LAPF), representative of a novel family of PH and FYVE domain-containing proteins, induces caspase-independent apoptosis via the lysosomal-mitochondrial pathway","volume":"280","year":"2005","journal-title":"J Biol Chem."}],"container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/uploads\/attached\/file\/20240529\/20240529135928_42173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:34:05Z","timestamp":1733520845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v25n2\/56805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1,26]]}},"alternative-id":["0965-0407(20170126)25:2L.259;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504016x14732503870766","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,26]]}}}